Showing results (561-570 of 726) with videos related to
Sort By:
Pageof 73
Cell Reports|September 15, 2015
TCF1 Is Required for the T Follicular Helper Cell Response to Viral InfectionTuoqi Wu, Hyun Mu Shin, E Ashley Moseman, et al.The Lancet. Oncology|August 15, 2015
Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: two randomised, active-controlled, double-blind, phase 3 trialsBernardo L Rapoport, Martin R Chasen, Cesare Gridelli, et al.Oncotarget|November 20, 2019
Efficacy and safety of buparlisib, a PI3K inhibitor, in patients with malignancies harboring a PI3K pathway activation: a phase 2, open-label, single-arm studySarina A Piha-Paul, Matthew H Taylor, Daniel Spitz, et al.BMC Health Services Research|December 21, 2019
THRIVE study protocol: a randomized controlled trial evaluating a web-based app and tailored messages to improve adherence to adjuvant endocrine therapy among women with breast cancerAndrew J Paladino, Janeane N Anderson, Rebecca A Krukowski, et al.The Journal of Experimental Medicine|February 18, 2009
Follicular helper T cells are required for systemic autoimmunityMichelle A Linterman, Robert J Rigby, Raphael K Wong, et al.Nano Letters|June 9, 2011
Radiation engineering of optical antennas for maximum field enhancementTae Joon Seok, Arash Jamshidi, Myungki Kim, et al.American Journal of Clinical Oncology|April 13, 1999
Adjuvant dose-intense chemotherapy with peripheral blood stem cell support in stage II-III breast cancer with five to nine involved axillary lymph nodesL S Schwartzberg, R Birch, K W Tauer, et al.The Oncologist|December 17, 2022
Duration of Chemotherapy-Induced Nausea and Vomiting (CINV) as a Predictor of Recurrent CINV in Later CyclesRudolph Navari, Gary Binder, Alex Molasiotis, et al.Journal of Medical Case Reports|February 20, 2020
Unusual recurrent metastasizing benign breast papilloma: a case reportAmit L Jain, Janice Mullins, Justin R Smith, et al.Cytotherapy|August 13, 2002
Breast tumor contamination of PBSC harvests: tumor depletion by positive selection of CD34(+) cellsJ Burgess, B Mills, M Griffith, et al.Pageof 73